Pfizer Inc (PFE)

$27.26 -0.39 (-1.41%)
Market Cap 157.21B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.56
Forward PE 9.31
Profit Margin 12.42%
Debt to Equity Ratio 0.66
Volume 41,321,600
Avg Vol 48,193,785
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 85%
Beta 0.47
Analysts Sell
Price Target $28.58

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Paulzk
Paulzk Mar. 3 at 1:10 AM
$PFE Pharma was unloved today as was consumer staples. VanEck Pharmaceutical ETF (PPH) 110.27 -1.43 (-1.28%) Flight to safety failed today. iShares US Consumer Staples ETF (IYK) 76.77 -0.87 (-1.12%)
0 · Reply
sam92
sam92 Mar. 3 at 1:02 AM
$PFE Momentum Momentum for PFE is strongly bullish. The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares. As of 4:00 PM ET Monday, 03/02/2026
0 · Reply
Thaigrlsrk
Thaigrlsrk Mar. 3 at 12:30 AM
$SRPT Anybody konw what he's talking about? A major breakthrough in rare disease research from $SRPT and $BMRN offers hope for patients with muscular dystrophy, attracting acquisition interest from large pharma $PFE and NVS This was a post on X.
1 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 2 at 11:13 PM
$PFE who’s feeling a cheeky 27.00 stop loss raid tomorrow morning?
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 2 at 11:01 PM
$PFE SOFI is my other stock and the CEO just bought another 1 mil worth of shares… Albert take notes
0 · Reply
Initiator1
Initiator1 Mar. 2 at 10:16 PM
$PFE $QURE $SRPT Prasad has been pushing around the smaller biotechs with limited capacity to fight back by moving goal posts. With industry heavy weights realizing his nonsense and fighting back, let’s see how long he lasts.
1 · Reply
Initiator1
Initiator1 Mar. 2 at 9:38 PM
$SRPT $QURE $PFE https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-flags-issues-with-fdas-vaccine-leadership-2026-03-02/
0 · Reply
dR_HumanEvolution
dR_HumanEvolution Mar. 2 at 8:54 PM
$BMY $IDYA $IMCR $PFE $REPL
0 · Reply
erevnon
erevnon Mar. 2 at 8:13 PM
Argus Research upgrades Pfizer $PFE from Hold to Buy and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 2 at 7:54 PM
$PFE as soon as I try to buy my calls back it starts going vertical… Checks out
1 · Reply
Latest News on PFE
Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 2, 2026, 1:27 PM EST - 7 hours ago

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 10 hours ago

Pfizer CEO flags issues with FDA's vaccine leadership

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

Mar 2, 2026, 4:51 AM EST - 16 hours ago

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

ABBV AMGN AVGO BTI DIV ENB GTY

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

Mar 1, 2026, 8:10 AM EST - 1 day ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

ARCC BBVA E EQNR ETD FINV GSL

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 3 days ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

Feb 26, 2026, 7:48 AM EST - 4 days ago

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

BBY CAG EQR FRT KEY KMI LYB

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 6 days ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 6 days ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 6 days ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 7 days ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 7 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Feb 20, 2026, 11:47 PM EST - 9 days ago

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 12 days ago

Is There 25% Downside For Pfizer Stock?

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Feb 18, 2026, 11:30 AM EST - 12 days ago

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Pfizer: The Rebound Looks Unsustainable

Feb 17, 2026, 5:42 PM EST - 13 days ago

Pfizer: The Rebound Looks Unsustainable

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 13 days ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 17 days ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 18 days ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Pfizer: A Great Opportunity Post Earnings

Feb 11, 2026, 6:08 PM EST - 19 days ago

Pfizer: A Great Opportunity Post Earnings

2 Urgent Sells And 2 No Brainer Dividend Buys

Feb 11, 2026, 4:06 PM EST - 19 days ago

2 Urgent Sells And 2 No Brainer Dividend Buys

ABBV AEP AMGN BMY ESS HASI HD

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 19 days ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 20 days ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Feb 8, 2026, 10:19 PM EST - 21 days ago

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 24 days ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

Feb 6, 2026, 7:25 AM EST - 24 days ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

ARCC ARLP CNQ EPD EQNR F FINV

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 24 days ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 25 days ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Feb 3, 2026, 3:00 PM EST - 27 days ago

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Pfizer: Messy Q4 Earnings Mask An Improving Business

Feb 3, 2026, 2:02 PM EST - 27 days ago

Pfizer: Messy Q4 Earnings Mask An Improving Business

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 27 days ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 27 days ago

Silver Surges Over 15%; Pfizer Earnings Top Views

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Feb 3, 2026, 11:56 AM EST - 27 days ago

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

Feb 3, 2026, 11:17 AM EST - 27 days ago

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

MRK

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Feb 3, 2026, 10:15 AM EST - 27 days ago

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Feb 3, 2026, 8:50 AM EST - 27 days ago

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Feb 3, 2026, 8:17 AM EST - 27 days ago

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Feb 3, 2026, 7:28 AM EST - 27 days ago

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Feb 3, 2026, 7:21 AM EST - 27 days ago

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Feb 3, 2026, 7:18 AM EST - 27 days ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street.

Feb 3, 2026, 7:02 AM EST - 27 days ago

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street.

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Feb 3, 2026, 6:57 AM EST - 27 days ago

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Pfizer beats fourth-quarter profit estimates on strong drug demand

Feb 3, 2026, 6:50 AM EST - 27 days ago

Pfizer beats fourth-quarter profit estimates on strong drug demand

Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial

Feb 3, 2026, 6:45 AM EST - 27 days ago

Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Feb 3, 2026, 6:45 AM EST - 27 days ago

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

Feb 3, 2026, 6:40 AM EST - 27 days ago

Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer

Feb 2, 2026, 8:42 AM EST - 4 weeks ago

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer

SNY

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Feb 2, 2026, 1:01 AM EST - 4 weeks ago

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

5 'Safer' Dividend Buys In Barron's 23 Better January Bets Than T-Bill

Jan 31, 2026, 3:47 AM EST - 4 weeks ago

5 'Safer' Dividend Buys In Barron's 23 Better January Bets Than T-Bill

BBY CAG EQR FRT KEY LYB MAA

Pfizer: Buyer Beware, The Risk Outweighs The Reward

Jan 30, 2026, 10:31 AM EST - 4 weeks ago

Pfizer: Buyer Beware, The Risk Outweighs The Reward

Why Dividend Stocks Are Essential For What Comes Next

Jan 30, 2026, 7:30 AM EST - 4 weeks ago

Why Dividend Stocks Are Essential For What Comes Next

AM CAG EPD ET KMI LLY MPLX

Paulzk
Paulzk Mar. 3 at 1:10 AM
$PFE Pharma was unloved today as was consumer staples. VanEck Pharmaceutical ETF (PPH) 110.27 -1.43 (-1.28%) Flight to safety failed today. iShares US Consumer Staples ETF (IYK) 76.77 -0.87 (-1.12%)
0 · Reply
sam92
sam92 Mar. 3 at 1:02 AM
$PFE Momentum Momentum for PFE is strongly bullish. The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares. As of 4:00 PM ET Monday, 03/02/2026
0 · Reply
Thaigrlsrk
Thaigrlsrk Mar. 3 at 12:30 AM
$SRPT Anybody konw what he's talking about? A major breakthrough in rare disease research from $SRPT and $BMRN offers hope for patients with muscular dystrophy, attracting acquisition interest from large pharma $PFE and NVS This was a post on X.
1 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 2 at 11:13 PM
$PFE who’s feeling a cheeky 27.00 stop loss raid tomorrow morning?
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 2 at 11:01 PM
$PFE SOFI is my other stock and the CEO just bought another 1 mil worth of shares… Albert take notes
0 · Reply
Initiator1
Initiator1 Mar. 2 at 10:16 PM
$PFE $QURE $SRPT Prasad has been pushing around the smaller biotechs with limited capacity to fight back by moving goal posts. With industry heavy weights realizing his nonsense and fighting back, let’s see how long he lasts.
1 · Reply
Initiator1
Initiator1 Mar. 2 at 9:38 PM
$SRPT $QURE $PFE https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-flags-issues-with-fdas-vaccine-leadership-2026-03-02/
0 · Reply
dR_HumanEvolution
dR_HumanEvolution Mar. 2 at 8:54 PM
$BMY $IDYA $IMCR $PFE $REPL
0 · Reply
erevnon
erevnon Mar. 2 at 8:13 PM
Argus Research upgrades Pfizer $PFE from Hold to Buy and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 2 at 7:54 PM
$PFE as soon as I try to buy my calls back it starts going vertical… Checks out
1 · Reply
MrPeanutEsquire
MrPeanutEsquire Mar. 2 at 7:52 PM
$PFE Its looking like Iran wont be buying any drugs from us for awhile. I hope that doesnt hit the bottom line too much
1 · Reply
barnml2006
barnml2006 Mar. 2 at 7:49 PM
$PFE So this still hasn't done much since I left. Been trying my hand at $SNAP better chance of a payoff.
0 · Reply
smartfellar
smartfellar Mar. 2 at 6:49 PM
$DIS and $PFE are two shit-birds that flock together.
0 · Reply
EmbraceVolatility
EmbraceVolatility Mar. 2 at 6:48 PM
$PFE https://www.gurufocus.com/news/8670034/pfizer-pfe-rating-upgraded-to-buy-by-argus-research-pfe-stock-news
0 · Reply
ZacksResearch
ZacksResearch Mar. 2 at 6:04 PM
$PFE up 11% in 2026… but is this rally built to last? 🤔 Flat guidance, falling COVID sales, and looming patent cliffs are casting a shadow over the rebound story. An 11% move sounds great — but if growth drivers are fading, you’ve got to question how durable this run really is. Buy, sell, or hold here? Get the full breakdown before making your next move 👉 https://www.zacks.com/stock/news/2877583/pfizer-stock-buy-sell-or-hold-after-its-11-rally-so-far-in-2026?cid=sm-stocktwits-2-2877583-teaser-35771&ADID=SYND_STOCKTWITS_TWEET_2_2877583_TEASER_35771
0 · Reply
ZacksResearch
ZacksResearch Mar. 2 at 5:04 PM
$PFE on the rise, but is it a long-term play? 🤔 Despite an 11% rise so far in 2026 and strong oncology sales growth, Pfizer's guidance disappoints with flat revenue expectations and looming patent expirations. The company's pipeline rebuild might drive growth post-2028, but short-term investors should be wary. Discover more about PFE's outlook here 👉 https://www.zacks.com/stock/news/2877583/pfizer-stock-buy-sell-or-hold-after-its-11-rally-so-far-in-2026?cid=sm-stocktwits-2-2877583-body-35770&ADID=SYND_STOCKTWITS_TWEET_2_2877583_BODY_35770
0 · Reply
DailyAnalysis
DailyAnalysis Mar. 2 at 4:51 PM
$PFE is bottoming on 1W as its oncology pipeline gains FDA traction. 1D STOCH is turning bullish while 4H and 30M CCI indicate high momentum. Watch for RSI to clear 60 for a sustained trend reversal. @DailyAnalysis
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 2 at 4:09 PM
$PFE - Based chad Al
0 · Reply
taxplanr
taxplanr Mar. 2 at 3:35 PM
$BNTX $MRNA $PFE
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 2 at 3:13 PM
$PFE - Recovery for thee, not for me
1 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 2 at 2:56 PM
$PFE a lot of 27.50 and 28.00 calls this week
0 · Reply
TheBlackBerrry
TheBlackBerrry Mar. 2 at 10:06 AM
$NVO novo nordisk NEWS, this finally runs today. 500 million imvestment in making weightloss pills in ireland 🙏🚀 $HIMS $LLY $PFE $SPY
1 · Reply